• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

A Dilemma for Governments: How to Pay for Million-Dollar Therapies

The New York Times – Business:

A wave of transformative but hugely expensive treatments is challenging the budgets of health systems in wealthy nations. Now countries with far fewer resources are wrestling with how to cover the therapies.

Rebecca Robbins
Author: Rebecca Robbins

This post first appeared in The New York Times – Business. Read the original article.

Written by

Rebecca Robbins

in

Brazil, Children and Childhood, Disabilities, Drugs (Pharmaceuticals), Genetic Engineering, Genetics and Heredity, Medicine and Health, Novartis AG, Spinal Muscular Atrophy, Suits and Litigation (Civil)
←Long Covid Is Keeping Significant Numbers of People Out of Work, Study Finds
Judge To Hold Hearing Over Georgia Special Grand Jury Report→

More posts

  • New CEO Steve O’Donnell vows to unite NASCAR and return the fun

  • ‘Fallout’ Cast & Creators On Navigating A World Full Of Complicated Characters Who Might “Bring A Gun To A Knife Fight” — Contenders TV

  • Fans Dance to ‘Michael’ Biopic in Theaters During Debut Weekend

  • Camilla takes missing Winnie-the-Pooh stuffed toy to New York to complete set

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube